ティッシュ心臓弁:医療機器パイプライン分析2017

GlobalDataが発行した調査報告書(GDME0439EPD)
◆英語タイトル:Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017
◆商品コード:GDME0439EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年9月8日
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,356,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Tissue Heart Valves – Medical Devices Pipeline Assessment, 2017
Summary

GlobalData’s Medical Devices sector report, “Tissue Heart Valves – Medical Devices Pipeline Assessment, 2017″ provides an overview of Tissue Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Tissue Heart Valves under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Tissue Heart Valves under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Tissue Heart Valves Overview 7
3 Products under Development 8
3.1 Tissue Heart Valves – Pipeline Products by Stage of Development 8
3.2 Tissue Heart Valves – Pipeline Products by Segment 9
3.3 Tissue Heart Valves – Pipeline Products by Territory 10
3.4 Tissue Heart Valves – Pipeline Products by Regulatory Path 11
3.5 Tissue Heart Valves – Pipeline Products by Estimated Approval Date 12
3.6 Tissue Heart Valves – Ongoing Clinical Trials 13
4 Tissue Heart Valves – Pipeline Products under Development by Companies 14
4.1 Tissue Heart Valves Companies – Pipeline Products by Stage of Development 14
4.2 Tissue Heart Valves – Pipeline Products by Stage of Development 15
5 Tissue Heart Valves Companies and Product Overview 16
5.1 Abbott Vascular Inc Company Overview 16
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Children’s Hospital Boston Company Overview 19
5.2.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Colibri Heart Valve, LLC Company Overview 20
5.3.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 CorMatrix Cardiovascular Inc Company Overview 22
5.4.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 CryoLife Inc Company Overview 28
5.5.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Cytograft Tissue Engineering Inc (Inactive) Company Overview 30
5.6.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Daidalos Solutions BV Company Overview 31
5.7.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 Edwards Lifesciences Corp Company Overview 34
5.8.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 34
5.9 Medtronic plc Company Overview 42
5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 42
5.10 Revivicor Inc Company Overview 46
5.10.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 46
5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 47
5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 47
5.12 Stellenbosch University Company Overview 48
5.12.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 48
5.13 Tissue Regenix Ltd Company Overview 49
5.13.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
5.14 University of California Irvine Company Overview 52
5.14.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 52
5.15 University of Cambridge Company Overview 54
5.15.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 54
5.16 University of Minnesota Company Overview 55
5.16.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 55
5.17 ValveXchange, Inc. (Inactive) Company Overview 56
5.17.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 56
5.18 VueKlar Cardiovascular Ltd Company Overview 59
5.18.1 VueKlar Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
6 Tissue Heart Valves- Recent Developments 60
6.1 Aug 23, 2017: OmniGuide Appoints Ajay Bhave as its Chief Technology Officer 60
6.2 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 60
6.3 Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results 63
6.4 Aug 04, 2017: LivaNovas Perceval Sutureless Aortic Heart Valve Awarded New Technology Add-on Payment from the Center for Medicare and Medicaid Services 64
6.5 Aug 02, 2017: Medtronic Expands Heart Valve Portfolio with FDA Approval and CE Mark of the Avalus Surgical Aortic Valve 65
6.6 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 65
6.7 Jul 05, 2017: Edward’s INSPIRIS RESILIA Valve Receives FDA Approval 67
6.8 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 68
6.9 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 68
6.10 May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer 71
6.11 May 04, 2017: LivaNova Announces New Data Reaffirming Value of Perceval for Aortic Valve Replacement in Aortic Stenosis Patients 71
6.12 May 03, 2017: LivaNova Reports First Quarter 2017 Results 73
6.13 Apr 28, 2017: LivaNova to Unveil New Data Further Demonstrating the Perceval Sutureless Valve is a Safe and Effective Aortic Valve Replacement for Patients 74
6.14 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 75
6.15 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 76
6.16 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation 77
6.17 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance 78
6.18 Mar 14, 2017: Medtronic Melody Transcatheter Pulmonary Valve First of Its Kind to Receive FDA Approval for Implantation in Failed Surgical Pulmonary Heart Valves 78
6.19 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results 79
6.20 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange 81
6.21 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 81
6.22 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 84
6.23 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 85
6.24 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 86
6.25 Jan 27, 2017: New Data Reinforce the Clinical Value of the Perceval Sutureless Valve as a Safe and Effective Bioprosthesis for Patients in Need of Aortic Valve Replacement 87
6.26 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 88
6.27 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 90
6.28 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 92
6.29 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 93
6.30 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester 94
6.31 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results 94
6.32 Nov 01, 2016: Early And Sustained Quality Of Life Improvements Seen For Intermediate Risk Patients Treated With Edwards Transcatheter Valves 96
6.33 Oct 31, 2016: EDWARDS INTUITY Elite Rapid Deployment Valve Approved In Canada 96
6.34 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 97
6.35 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 98
6.36 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 98
6.37 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 100
6.38 Oct 03, 2016: Medtronic Avalus Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results 101
6.39 Sep 29, 2016: Edwards INSPIRIS RESILIA Valve Receives CE Mark 102
6.40 Sep 29, 2016: LivaNova Announces Half-Year Financial Report 103
6.41 Sep 28, 2016: Northwestern Medicine First in Illinois to Implant New FDA-Approved Aortic Valve 111
6.42 Sep 27, 2016: Artificial Blood Vessels Developed in the Lab can Grow with the Recipient 112
6.43 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 113
7 Appendix 115
7.1 Methodology 115
7.2 About GlobalData 118
7.3 Contact Us 118
7.4 Disclaimer 118

1.1 List of Tables
Table 1: Tissue Heart Valves - Pipeline Products by Stage of Development 8
Table 2: Tissue Heart Valves - Pipeline Products by Segment 9
Table 3: Tissue Heart Valves - Pipeline Products by Territory 10
Table 4: Tissue Heart Valves - Pipeline Products by Regulatory Path 11
Table 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date 12
Table 6: Tissue Heart Valves - Ongoing Clinical Trials 13
Table 7: Tissue Heart Valves Companies - Pipeline Products by Stage of Development 14
Table 8: Tissue Heart Valves - Pipeline Products by Stage of Development 15
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status 16
Table 11: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description 16
Table 12: Abbott Vascular Inc - Ongoing Clinical Trials Overview 17
Table 13: Tendyne Bioprosthetic Mitral Valve Implantation System - Early Feasibility Study of the Tendyne Mitral Valve System 18
Table 14: Tendyne Bioprosthetic Mitral Valve Implantation System - Safety and Performance of the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) in Inoperable Subjects with Mitral Regurgitation (MR) 18
Table 15: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 19
Table 16: Heart Valve Leaflet - Product Status 19
Table 17: Heart Valve Leaflet - Product Description 19
Table 18: Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 19: Pulmonary Valve - Product Status 20
Table 20: Pulmonary Valve - Product Description 20
Table 21: Sutureless Surgical Aortic Valve - Product Status 21
Table 22: Sutureless Surgical Aortic Valve - Product Description 21
Table 23: CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 24: CorMatrix ECM - Heart Valve Repair - Product Status 22
Table 25: CorMatrix ECM - Heart Valve Repair - Product Description 22
Table 26: CorMatrix ECM - Heart Valve Replacement - Product Status 23
Table 27: CorMatrix ECM - Heart Valve Replacement - Product Description 23
Table 28: CorMatrix ECM Tricuspid Heart Valve - Product Status 23
Table 29: CorMatrix ECM Tricuspid Heart Valve - Product Description 24
Table 30: CorMatrix Cardiovascular Inc - Ongoing Clinical Trials Overview 25
Table 31: CorMatrix ECM - Heart Valve Repair - Cardial Infarct Repair Using CorMatrix-ECM: Clinical Feasibility Study 26
Table 32: CorMatrix ECM Tricuspid Heart Valve - CorMatrix ECM Tricuspid Valve Replacement Safety and Early Feasibility 27
Table 33: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 34: CryoValve SGAV - Product Status 28
Table 35: CryoValve SGAV - Product Description 28
Table 36: Synergraft Xenograft Heart Valve - Product Status 29
Table 37: Synergraft Xenograft Heart Valve - Product Description 29
Table 38: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
Table 39: Cytograft Valve - Product Status 30
Table 40: Cytograft Valve - Product Description 30
Table 41: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 31
Table 42: Sutureless Aortic valve Prosthesis - Product Status 31
Table 43: Sutureless Aortic valve Prosthesis - Product Description 31
Table 44: Sutureless Mitral Valve Prostheses - Product Status 32
Table 45: Sutureless Mitral Valve Prostheses - Product Description 32
Table 46: Sutureless Tricuspid Valve Prostheses - Product Status 32
Table 47: Sutureless Tricuspid Valve Prostheses - Product Description 33
Table 48: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 34
Table 49: GLX Aortic Conduit - Product Status 34
Table 50: GLX Aortic Conduit - Product Description 35
Table 51: INSPIRIS RESILIA Aortic Valve - Product Status 35
Table 52: INSPIRIS RESILIA Aortic Valve - Product Description 35
Table 53: INTUITY Valve System - Product Status 36
Table 54: INTUITY Valve System - Product Description 36
Table 55: KONECT Conduit - Product Status 36
Table 56: KONECT Conduit - Product Description 37
Table 57: Magna EASE Surgical Valve With GLX - Product Status 37
Table 58: Magna EASE Surgical Valve With GLX - Product Description 37
Table 59: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview 38
Table 60: INTUITY Valve System - A Randomized Comparison of the EDWARDS INTUITY Valve System and Commercially Available Aortic Bioprostheses in Subjects Undergoing Surgical Aortic Valve Replacement 39
Table 61: INTUITY Valve System - Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement 39
Table 62: INTUITY Valve System - Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve 39
Table 63: Magna EASE Surgical Valve With GLX - Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients 40
Table 64: Magna EASE Surgical Valve With GLX - Edwards Receives IDE for U.S. Clinical Trial of New Heart Valve Tissue Treatment Platform 40
Table 65: INSPIRIS RESILIA Aortic Valve - Prospective, Non-randomized, Multicenter Clinical Evaluation of the Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000a and 11000m) with a New Tissue Treatment Platform: COMMENCE 41
Table 66: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 67: Avalus Surgical Aortic Valve - Product Status 42
Table 68: Avalus Surgical Aortic Valve - Product Description 42
Table 69: Closed-Chest Aortic Tissue Valve - Product Status 43
Table 70: Closed-Chest Aortic Tissue Valve - Product Description 43
Table 71: Enable Valve-Beating Heart Procedure - Product Status 43
Table 72: Enable Valve-Beating Heart Procedure - Product Description 43
Table 73: Medtronic plc - Ongoing Clinical Trials Overview 44
Table 74: Avalus Surgical Aortic Valve - Medtronic Pericardial Surgical Aortic Valve Replacement Pivotal Trial a Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients with Aortic Valve Disease 45
Table 75: Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Table 76: Heart Valve - Product Status 46
Table 77: Heart Valve - Product Description 46
Table 78: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 47
Table 79: Tissue Based Cardiac Valve - Product Status 47
Table 80: Tissue Based Cardiac Valve - Product Description 47
Table 81: Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 48
Table 82: Percutaneous Heart Valve - Product Status 48
Table 83: Percutaneous Heart Valve - Product Description 48
Table 84: Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
Table 85: Cardiopure - Aortic Heart Valve - Product Status 49
Table 86: Cardiopure - Aortic Heart Valve - Product Description 49
Table 87: Cardiopure - Pulmonary Heart Valve - Product Status 50
Table 88: Cardiopure - Pulmonary Heart Valve - Product Description 50
Table 89: CardioPure HV - Product Status 50
Table 90: CardioPure HV - Product Description 51
Table 91: University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 52
Table 92: Bileaflet Bioprosthetic Mitral Valve - Product Status 52
Table 93: Bileaflet Bioprosthetic Mitral Valve - Product Description 52
Table 94: Heart Valve Leaflets - Product Status 53
Table 95: Heart Valve Leaflets - Product Description 53
Table 96: University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 54
Table 97: Polymeric Heart Valve - Product Status 54
Table 98: Polymeric Heart Valve - Product Description 54
Table 99: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 55
Table 100: Tissue-Engineered Vessel Graft - Product Status 55
Table 101: Tissue-Engineered Vessel Graft - Product Description 55
Table 102: ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 56
Table 103: Vanguard System - Product Status 56
Table 104: Vanguard System - Product Description 56
Table 105: Vitality Exchangeable Valve System - Product Status 57
Table 106: Vitality Exchangeable Valve System - Product Description 57
Table 107: VXi Vanguard II - Product Status 57
Table 108: VXi Vanguard II - Product Description 58
Table 109: VueKlar Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
Table 110: MR-Enhancing Percutaneous Heart Valve - Product Status 59
Table 111: MR-Enhancing Percutaneous Heart Valve - Product Description 59
Table 112: Glossary 117

1.2 List of Figures
Figure 1: Tissue Heart Valves - Pipeline Products by Stage of Development 8
Figure 2: Tissue Heart Valves - Pipeline Products by Segment 9
Figure 3: Tissue Heart Valves - Pipeline Products by Territory 10
Figure 4: Tissue Heart Valves - Pipeline Products by Regulatory Path 11
Figure 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date 12
Figure 6: Tissue Heart Valves - Ongoing Clinical Trials 13

【掲載企業】

Abbott Vascular Inc
Children's Hospital Boston
Colibri Heart Valve, LLC
CorMatrix Cardiovascular Inc
CryoLife Inc
Cytograft Tissue Engineering Inc
Daidalos Solutions BV
Edwards Lifesciences Corp
Medtronic plc
Revivicor Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
Stellenbosch University
Tissue Regenix Ltd
University of California Irvine
University of Cambridge
University of Minnesota
ValveXchange, Inc.
VueKlar Cardiovascular Ltd

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ティッシュ心臓弁:医療機器パイプライン分析2017(Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆